Fig. 2From: Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung diseasePrognostic analysis. a Estimation of the cutoff for serum soluble CD163. b Survival curves in patients with polymyositis/dermatomyositis-related interstitial lung disease. The cutoff for serum soluble CD163 is set at 800Â ng/mL by comparing the integrated area under the curve (iAUC)Back to article page